Cure Today

Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...
Seeking Alpha

BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection

TEL AVIV, Israel and WALTHAM, Mass., Sept. 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in ...
Morningstar

Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing ...
Mid-Day

Stem Cell Leukemia Conditions and Indications: When Stem Cell Therapy Becomes a Critical Option

At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...
Becker's ASC

Stem Cell Treatment & Minimally Invasive Spine Stabilization in Outpatient Surgery Centers: Q&A With Laser Spine Institute on New Procedures

The RegenaDISC procedure was pioneered by Mark Flood, DO, chief of surgical innovation at Laser Spine Institute, and combines minimally invasive surgical techniques with stem cell treatment. The ...